OPTIMAL is being conducted by the Immune Tolerance Network and sponsored by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health ...
OPTIMAL is a clinical trial for liver transplant recipients that will gradually reduce participants' anti-rejection medication(s) over a period of time.